Multifunctional nano-MOFs based on tumor microenvironment modulation for detecting singlet oxygen and enhancing

Yongdan Wang1, Linshan Jia1, Xiaotong Li1

  • 1Department of Pharmaceutical Analysis, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.

Nanoscale
|October 17, 2025
PubMed

Insights

This study introduces a novel nanosystem to improve photodynamic therapy (PDT) by regulating the tumor microenvironment and detecting singlet oxygen (1O2). The system enhances PDT efficacy by reducing glutathione (GSH) depletion and enabling precise treatment monitoring.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Photodynamic Therapy

Background:

  • Photodynamic therapy (PDT) is a promising cancer treatment but faces challenges from the tumor microenvironment (TME), including glutathione (GSH) overexpression that depletes singlet oxygen (1O2).
  • The precise monitoring of 1O2 levels during PDT is crucial for optimizing therapeutic outcomes and avoiding insufficient or excessive treatment.

Purpose of the Study:

  • To develop a multifunctional nanosystem for TME regulation, 1O2 generation, and real-time 1O2 detection to overcome PDT limitations.
  • To enhance PDT efficacy by mitigating GSH-mediated 1O2 depletion and enabling accurate treatment control.

Main Methods:

  • Design and synthesis of a DPA-MOF@MnO2-Ce6@PEG multifunctional nanosystem.
  • Utilizing MnO2 to modulate GSH levels, Ce6 as a photosensitizer, DPA-MOF for 1O2 capture and detection, and PEG for stability.
  • Evaluating the nanosystem's 1O2 detection capability, GSH depletion capacity, and antitumor activity in vitro using 4T1 and MCF-7 cells.

Main Results:

  • The DPA-MOF@MnO2-Ce6@PEG nanosystem effectively detected 1O2 levels.
  • The system demonstrated significant GSH depletion capacity within the TME.
  • Potent antitumor activity was observed in 4T1 and MCF-7 tumor cells, indicating enhanced PDT efficacy.

Conclusions:

  • The developed multifunctional nanosystem offers a promising strategy for precise PDT by addressing TME abnormalities and enabling real-time monitoring.
  • This approach provides a viable solution for overcoming GSH-induced 1O2 depletion, thereby improving PDT outcomes in cancer therapy.

Related Concept Videos